We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
51
CALL
Madrigal Pharmaceuticals
MDGL
$11.8B
$23.4M 0.36%
+160,000
New +$30.1M
TOST icon
52
Toast
TOST
$20.3B
$23.2M 0.36%
1,237,359
+273,359
+28% +$5.93M
MGNX icon
53
MacroGenics
MGNX
$250M
$22M 0.34%
4,712,000
-888,000
-16% -$4.42M
JNJ icon
54
Johnson & Johnson
JNJ
$623B
$20.9M 0.32%
134,378
-325,622
-71% -$53.7M
IMCR icon
55
Immunocore
IMCR
$1.67B
$20.8M 0.32%
400,000
-28,000
-7% -$1.66M
KURA icon
56
Kura Oncology
KURA
$830M
$20.4M 0.31%
2,236,000
+112,000
+5% +$1.14M
EL icon
57
Estee Lauder
EL
$31.6B
$20.2M 0.31%
+139,809
New +$23.3M
BCYC
58
Bicycle Therapeutics
BCYC
$276M
$20.1M 0.31%
1,000,000
+124,000
+14% +$2.84M
UBER icon
59
Uber
UBER
$137B
$20M 0.31%
434,130
-65,870
-13% -$3.01M
NOMD icon
60
Nomad Foods
NOMD
$1.65B
$19.6M 0.3%
1,287,195
+37,195
+3% +$643K
THS
61
DELISTED
Treehouse Foods
THS
$19.2M 0.29%
+439,952
New +$21.1M
RIGL icon
62
Rigel Pharmaceuticals
RIGL
$732M
$18.5M 0.28%
1,713,600
+3,600
+0.2% +$43.3K
ERAS icon
63
Erasca
ERAS
$6.45B
$16.5M 0.25%
8,356,000
+500,000
+6% +$1.28M
DECK icon
64
Deckers Outdoor
DECK
$13.6B
$16.4M 0.25%
191,580
-24,420
-11% -$2.19M
AUTL
65
Autolus Therapeutics
AUTL
$500M
$16.1M 0.25%
6,900,000
-364,000
-5% -$1.04M
ROST icon
66
Ross Stores
ROST
$81B
$15.8M 0.24%
139,719
-281
-0.2% -$32.2K
MDGL icon
67
Madrigal Pharmaceuticals
MDGL
$11.8B
$15.8M 0.24%
108,000
-28,000
-21% -$5.27M
WDAY icon
68
Workday
WDAY
$41.9B
$15.5M 0.24%
71,953
-10,047
-12% -$2.33M
SN icon
69
SharkNinja
SN
$25.3B
$15.2M 0.23%
+327,000
New +$12M
REKR icon
70
Rekor Systems
REKR
$91.8M
$14.6M 0.22%
+5,164,000
New +$15.7M
LLAP
71
DELISTED
Terran Orbital Corporation
LLAP
$14.5M 0.22%
17,364,285
+2,039,285
+13% +$2.7M
LOW icon
72
Lowe's Companies
LOW
$123B
$14.4M 0.22%
69,412
-13,588
-16% -$3.06M
FIVN icon
73
FIVE9
FIVN
$2.26B
$14.4M 0.22%
224,290
+100,290
+81% +$7.51M
DDOG icon
74
Datadog
DDOG
$102B
$14.4M 0.22%
157,580
-30,420
-16% -$3.01M
CDNA icon
75
CareDx
CDNA
$2.4B
$14.3M 0.22%
2,036,000
-1,288,000
-39% -$11.9M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.